Heparin Interpharma

Interpharma Pty Ltd is an Australian specialty pharmaceutical company and a subsidiary of the Austrian-based EVER Pharma. The company specializes in the registration, marketing, and distribution of a diverse portfolio of healthcare products, including injectable medicines, medical devices, and hospital supplies. Its key product, Heparin Interpharma (heparin sodium), is a TGA-approved anticoagulant indicated for the prophylaxis and treatment of deep vein thrombosis in adults. Interpharma acts as a local sponsor for international partners, leveraging its expertise in regulatory affairs and market access to bring essential therapies to the Australasian market.